Label-free infectious virus titers in 24 hours, not 5 to 10 days
TiterKinetix is viral infectivity assay software that turns brightfield time-lapse images from your plate imager into an infectious virus titer 24 hours after infection.
Infectious titer after infection, against 5 to 10 days for endpoint assays
Under 20% CV
From three wells per sample
24 samples
Per 96-well plate, with a reference standard on every plate
About 400
Samples per operator per week
21 CFR Part 11 + GMP
21 CFR Part 11 and GMP compliant with AuditSafe
TiterKinetix replaces endpoint TCID50 and plaque assays with the peer-reviewed kinetic infectious virus titer (KIT) assay: one dose in three wells per sample, no staining, and under 20% CV. It also measures neutralization and antiviral IC50, runs entirely on your own computers, and supports 21 CFR Part 11 with AuditSafe.
What TiterKinetix does
TiterKinetix measures infectious virus titer from label-free brightfield images of live cells. Your plate imager photographs every well each hour. TiterKinetix finds the cells in every image, measures the share that have rounded up or otherwise changed shape because of infection, and follows that change over 24 hours. A kinetic fit turns each well's curve into a single response time, and the software reads each sample's titer off a reference standard curve run on the same plate.
The result is an infectious titer for every sample, with QC metrics for the plate and a report ready for review, a day after infection. You do not need a reporter virus, antibodies, dyes, overlays or fixation. Nobody scores CPE by eye.
Why endpoint infectivity assays slow you down
Infectious titer is a critical quality attribute for oncolytic viruses, viral vaccines and other virus-based therapeutics. The standard ways of measuring it were designed for research labs, not for release and stability programs.
TCID50 assays infect a full serial dilution of each sample, wait for cytopathic effect to develop, then score each well positive or negative at one endpoint. A single TCID50 determination carried about 44% CV in the published comparison, and each sample can take a whole plate.
Plaque assays need a semisolid overlay, days of incubation, fixation and crystal violet staining, then a person counting plaques to get plaque-forming units per mL (PFU/mL). Manual plaque counting is slow and subjective, and many viruses do not form clear plaques at all. Focus forming assays add immunostaining on top.
Across a development or QC program that means 5 to 10 days before a lot can be released, results that vary between analysts, and a ceiling on how many samples one person can run.
How the kinetic infectious virus titer (KIT) assay works
Set up one plate. A reference standard dilution series, mock wells and up to 24 samples, each infected at a single dose in three wells. Setting up a full 96-well plate takes under 45 minutes.
Image it on your imager. The plate sits in your Cytation, Lionheart FX, BioSpa or Incucyte and is imaged in brightfield at an interval you choose, typically every hour for 24 hours.
Let TiterKinetix find the changed cells. The software classifies the cells in every image and calculates the percentage of infection-induced changed cells in each well at each time point.
Fit the kinetics. A kinetic model, configurable by the user, is fitted to each well across all time points to find its response time. Higher doses respond sooner, so response time tracks infectious dose.
Read the titer. Each sample is interpolated against the reference standard curve on the same plate. TiterKinetix reports the titer in the units assigned to your standard (for example TCID50/mL equivalents), with CV, curve fit quality and plate QC, in a report ready for review and sign-off.
TiterKinetix vs TCID50 vs plaque assays
How TiterKinetix compares with endpoint infectivity assays for 24 samples
About 72 h in the published comparison; up to 5 to 10 days for many viruses
Typically 2 to 14 days, depending on the virus
Wells per sample
3, at a single dose
A full serial dilution series
A serial dilution series
Plates for 24 samples
1
Up to 24
Several
Hands-on time, 24 samples
About 1.2 h
About 12 h
Overlay, staining and manual counting
Precision
Under 20% CV from three wells
About 44% CV for a single determination
Subjective manual counts
Staining or overlay
None
None, or a viability stain
Semisolid overlay, fixation, crystal violet or immunostain
Neutralization and IC50
Yes, same plate format
Separate assay
PRNT, counted by hand
21 CFR Part 11
With AuditSafe
Depends on your systems
Depends on your systems
TiterKinetix figures from Hotter et al. (2024) and TotalLab testing. Plaque assay duration from a 2022 bioRxiv preprint (see References).
Neutralization and antiviral IC50
TiterKinetix also measures how well an antibody or antiviral compound stops infection, on the same plate format, imager and software as a titer run.
A neutralizing antibody or an antiviral delays or prevents infection-induced cell changes, and a stronger effect delays them further. The published KIT work showed exactly this: a neutralizing antibody and a viral polymerase inhibitor each prevented infection-induced rounding. TiterKinetix measures that delay in every well and fits a dose-response curve to report IC50 for each sample.
Use it for:
Virus neutralization tests and microneutralization assays
Neutralizing antibody titers in vaccine development and serology
Antiviral compound screening and IC50 determination
Live-virus potency testing of antibody therapeutics
There are no plaques to count for a plaque reduction neutralization test (PRNT), no overlays and no immunostaining.
The KIT readout is stability-indicating, so it detects loss of infectivity in stressed and aged material. That makes it fit for release and stability testing of virus-based therapeutics as well as process and formulation development.
With AuditSafe, TotalLab software provides audit trails, electronic signatures, granular user permissions and image authenticity verification for FDA 21 CFR Part 11 and EU Annex 11. Every step from the raw images to the signed report stays inside one compliant system, and reports can be exported to your LIMS.
TiterKinetix runs entirely on your own computers, on Windows, macOS or Linux. Images, results and reports never leave your network, and there is no cloud upload to qualify.
Agilent BioTek BioSpa automated incubator, for unattended time-lapse imaging
Sartorius Incucyte live-cell analysis systems
It also works with most other automated imagers that capture time-lapse brightfield images of 96- or 384-well plates. Using something else? Ask us and we will check your instrument and image format.
TiterKinetix works for any virus and cell line combination in which infection changes the shape of infected cells, the classic cytopathic effect: rounding, detachment, fusion or other morphological change.
The published KIT assay was demonstrated with:
VSV-GP, an oncolytic vesicular stomatitis virus, in BHK-21 cells
Newcastle disease virus (NDV) in DF-1 chicken fibroblasts
Parapoxvirus ovis (ORFV) in HeLa cells
That covers lytic oncolytic viruses, live viral vaccines and vaccine vectors, and replicating viruses in research. Replication-defective vectors such as AAV and most lentiviral vectors cause no cytopathic effect, so they need a genome titer or reporter-based method instead.
Who uses TiterKinetix
Analytical development scientists building infectivity and potency assays
QC analysts running release and stability testing under GMP
Bioprocess and process development teams who need titers the next day
Formulation scientists comparing stability across conditions
Vaccine and serology teams measuring neutralizing antibodies
Antiviral discovery groups determining IC50
Academic virology labs studying replication kinetics and viral variants
Built on published science
TiterKinetix implements the kinetic infectious virus titer (KIT) assay, developed by scientists in a global pharmaceutical company's viral therapeutics group and published in the International Journal of Molecular Sciences in 2024. TotalLab built the software with the assay's developers.
"Our kinetic infectious virus titer (KIT) assay is stability-indicating and, due to its sensitive readout method, provides results within 24 h post-infection."
Hotter, D., Kunzelmann, M., et al. (2024). Int. J. Mol. Sci., 25, 8076.
Infectious titers were determined with the kinetic infectious virus titer (KIT) assay (Hotter et al., 2024). Cells were infected in 96-well plates with each sample at a single dose in triplicate alongside a reference standard dilution series, and imaged in brightfield every [1] h for 24 h on an [Agilent BioTek Cytation 5 / Sartorius Incucyte]. Images were analyzed and titers calculated in TiterKinetix [version] (TotalLab, Newcastle upon Tyne, UK).
Frequently asked questions
What is TiterKinetix?
TiterKinetix is label-free viral infectivity assay software from TotalLab. It analyzes brightfield time-lapse images from an automated plate imager, measures how infected cells change shape over time, and reports an infectious virus titer for each sample 24 hours after infection. It is built on the peer-reviewed kinetic infectious virus titer (KIT) assay (Hotter et al., 2024).
How is TiterKinetix different from a TCID50 assay?
A TCID50 assay infects a full dilution series, waits for cytopathic effect to develop, and scores wells by eye at a single endpoint. TiterKinetix images the plate every hour, fits a kinetic curve to the infection-induced cell changes in each well, and interpolates the sample against a reference standard on the same plate. It needs one dose in three wells per sample instead of a dilution series, reports at 24 hours, and gave under 20% CV from three wells in the published work, against about 44% CV for a single TCID50 determination.
Can TiterKinetix replace a plaque assay?
For viruses that change the morphology of infected cells, yes. TiterKinetix needs no semisolid overlay, no crystal violet or immunostaining and no manual plaque counting, and it also works for viruses that do not form clear plaques. Labs that need an orthogonal method during validation can keep the plaque assay alongside it.
Is TiterKinetix label-free?
Yes. TiterKinetix reads unstained brightfield images of live cells. There are no fluorescent reporter viruses, antibodies, dyes or fixation steps.
Which plate imagers does TiterKinetix work with?
TiterKinetix works with the Agilent BioTek Cytation 5 and Cytation 7, the Agilent BioTek Lionheart FX, Agilent BioTek BioSpa automated incubation with a Cytation, and the Sartorius Incucyte. It also works with most other automated imagers that capture time-lapse brightfield images of 96- or 384-well plates.
Which viruses can TiterKinetix titer?
Any virus and cell line combination where infection causes a measurable change in cell morphology, such as rounding. The published KIT assay used VSV-GP in BHK-21 cells, Newcastle disease virus (NDV) in DF-1 cells and parapoxvirus ovis (ORFV) in HeLa cells. Replication-defective vectors that cause no cytopathic effect, such as AAV, need a different readout.
How long does a TiterKinetix titer take?
Results are available 24 hours after infection. Plate setup takes under 45 minutes for a full 96-well plate, and the analysis from raw images to report is automated.
How many samples can one plate hold?
Up to 24 samples on a 96-well plate, each at a single dose in three wells, alongside a reference standard dilution series and mock wells. The format scales to 384-well plates. The published work reports about 400 samples per operator per week.
Can TiterKinetix run virus neutralization and antiviral IC50 assays?
Yes. A neutralizing antibody or an antiviral compound delays or prevents infection-induced cell changes, and TiterKinetix measures that effect in every well to report IC50. It is an alternative to manual plaque reduction neutralization tests (PRNT) and microneutralization scoring.
Is TiterKinetix suitable for GMP lot release and stability testing?
The KIT readout is stability-indicating, which makes it suitable for release and stability programs. With AuditSafe, TotalLab software provides audit trails, electronic signatures, granular user permissions and image authenticity verification for FDA 21 CFR Part 11 and EU Annex 11.
Does TiterKinetix upload data to the cloud?
No. TiterKinetix runs entirely on your own computers, on Windows, macOS or Linux. Images, results and reports stay inside your network.
Does TiterKinetix calculate TCID50 by Reed-Muench or Spearman-Kärber?
No. TiterKinetix reports a kinetic titer interpolated against your reference standard rather than an endpoint dilution titer. For endpoint TCID50 by Spearman-Kärber or Reed-Muench, use the free TotalLab TCID50 calculator.
How do I cite TiterKinetix in a publication?
Cite the KIT assay paper (Hotter et al., Int. J. Mol. Sci. 2024, 25, 8076) and name TiterKinetix software (TotalLab, Newcastle upon Tyne, UK) together with your imager and imaging interval. Suggested wording is in the How to cite section of this page.
Can I see TiterKinetix on my own virus?
Yes. Book a demo and the team will show TiterKinetix on your virus, cell line and imager, or on example data if you are still choosing an instrument.
Need something TiterKinetix doesn't do yet? Ask TotalLab.
References
Hotter, D., Kunzelmann, M., et al. (2024). High-Throughput Determination of Infectious Virus Titers by Kinetic Measurement of Infection-Induced Changes in Cell Morphology. Int. J. Mol. Sci., 25, 8076. https://doi.org/10.3390/ijms25158076